VRIEMPA M 5/500 TABLET
Generic Salt Composition: Empagliflozin 5mg + Metformin 500mg
Price: ₹30 MRP: ₹243.75
Save up to 88% compared to branded medicines.
Top Brand Substitutes & Equivalents
Jardiance Met, Synjardy, Empagliflozin Metformin Hydrochloride, Emaglo Met, Glimisave M, Glycomet Trio, Jardimet, Empa-M, Met-Empa, Zucmet, Empa-Met, Emmet, Empa-M 5/500, Metformin Empagliflozin, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500, Exermet 500, Metfor 500, Glycomet GP 1, Glycomet GP 2, Gluconorm-G 1, Gluconorm-G 2
Product Overview & Uses
VRIEMPA M 5/500 TABLET is a sophisticated oral antidiabetic medication categorized under Diabetes Care. It is specifically formulated for the management of Type 2 Diabetes Mellitus in adults. The dual-action mechanism of VRIEMPA M 5/500 TABLET involves Empagliflozin, which promotes the excretion of excess glucose through urine, and Metformin, which decreases hepatic glucose production and improves peripheral insulin sensitivity. This combination makes VRIEMPA M 5/500 TABLET a highly effective choice for patients who require more than monotherapy to reach their glycemic targets. Beyond blood sugar regulation, VRIEMPA M 5/500 TABLET is recognized for its potential to assist in weight management and provide cardiovascular protection, making it a cornerstone in modern diabetes management protocols. Patients prescribed VRIEMPA M 5/500 TABLET should adhere to a balanced diet and regular exercise regimen to maximize the therapeutic outcomes of this medication.